Could board games be used as an educational tool to help teach and raise awareness around some of the major challenges in infectious diseases? In this interview we speak to Salam Abbara about the game she has helped develop, which aims to help medical students learn and understand antibiotic prescribing.
Browsing: Clinical Management
New research has identified four novel sepsis phenotypes, suggesting these could be relevant for understanding the heterogeneity of treatment effects and help to explain recent clinical trial failures.
A second individual has achieved sustained remission from HIV-1 after ceasing antiretroviral treatment, according to researchers from University College London. Following a hematopoietic stem cell transplant and chemotherapy the patient has had undetectable viral loads for 18 months.
Healthcare Scientists are involved in 80% of the diagnosis provided to patients in the NHS, but who are Healthcare Scientists and what is it that they do?
A study published in the BMJ, involving more than 19 million patients, has concluded that 23.9% of antibiotic prescriptions given to outpatients in the US are inappropriate.
Meeting report: Non-tuberculous mycobacterial lung disease at the 2018 International Congress of the European Respiratory Society
The International Congress of the European Respiratory Society, 15–19 September, Paris (France), is the largest respiratory medicine meeting in the world. Find out about the latest research on non-tuberculous mycobacteria lung disease (NTM-LD) discussed at the 2018 congress in this report.
In line with World AIDS Day this year we spoke to Andy Ustianowski (North Manchester General Hospital, UK) about the new challenges facing people living with HIV, including aging healthily and happily.
Concurrent major US and Canadian clinical trials prove probiotics to be ineffective in combatting gastroenteritis in children.
By carefully considering the characteristics of certain old and new antibiotics, it may be possible to overcome many bacterial resistance mechanisms, including when more than one is present.
New data analysis of three clinical trials has suggested that a precision medicine approach could allow some pulmonary TB patients to have significantly shorter treatment periods.